[COVID-19: epidemiology and mutations : An update]
[COVID-19: 역학 및 돌연변이 : 업데이트]
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
Alpha
Alpha variant
antibody
antibody treatment
approach
AstraZeneca
B.1.1.28.1
B.1.1.7
B.1.351
B.1.617
bamlanivimab
Beta variant
Brazil
caused
circulating
coronavirus
Course
courses
decrease
delta variant
described
disease severity
dominant
Effectiveness
English
ENhance
Epidemiology
fatal disease
Germany
herd immunity
Immunity
India
Infection
infectiousness
Kingdom
less
life-threatening
Mild
moderate disease
monoclonal antibodies
monoclonal antibody
mortality risk
Mutation
mutations
neutralization ability
offer
outcome
P.1
pandemic
protective effect
rule
SARS-CoV-2
SARS-CoV‑2
severe acute respiratory syndrome Coronavirus
South Africa
Spread
symptomatic disease
the disease
the vaccine
vaccination
vaccination rate
Vaccinations
Vaccine
variant
variants
virus strain
virus variants
wild type
[DOI] 10.1007/s00117-021-00909-0 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s00117-021-00909-0 PMC 바로가기 [Article Type] Review